Jamison Private Wealth Management Inc. Boosts Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Jamison Private Wealth Management Inc. grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 16.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,539 shares of the medical equipment provider's stock after purchasing an additional 631 shares during the period. Jamison Private Wealth Management Inc.'s holdings in Intuitive Surgical were worth $2,369,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $26,000. Godsey & Gibb Inc. increased its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical in the 3rd quarter valued at about $33,000. Decker Retirement Planning Inc. bought a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $36,000. Finally, Capital Performance Advisors LLP acquired a new position in Intuitive Surgical during the 3rd quarter worth approximately $38,000. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Trading Down 4.0 %

NASDAQ ISRG traded down $24.61 during mid-day trading on Friday, hitting $584.05. The company's stock had a trading volume of 4,350,539 shares, compared to its average volume of 1,342,626. The firm has a market capitalization of $208.03 billion, a price-to-earnings ratio of 93.90, a PEG ratio of 5.19 and a beta of 1.39. The company's 50 day simple moving average is $547.16 and its 200 day simple moving average is $504.78. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Insider Buying and Selling at Intuitive Surgical

In other news, insider Jamie Samath sold 269 shares of the firm's stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $539.89, for a total value of $145,230.41. Following the transaction, the insider now owns 8,757 shares in the company, valued at $4,727,816.73. This trade represents a 2.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the transaction, the chief executive officer now directly owns 24,219 shares in the company, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 42,475 shares of company stock valued at $22,070,807. Corporate insiders own 0.90% of the company's stock.

Analysts Set New Price Targets

ISRG has been the subject of a number of analyst reports. Oppenheimer restated a "market perform" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. JPMorgan Chase & Co. increased their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a report on Friday. Morgan Stanley raised Intuitive Surgical from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Robert W. Baird increased their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the stock an "outperform" rating in a research report on Thursday, October 17th. Finally, Evercore ISI reissued a "cautious" rating on shares of Intuitive Surgical in a report on Friday, October 18th. One research analyst has rated the stock with a sell rating, three have given a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, Intuitive Surgical has an average rating of "Moderate Buy" and an average price target of $583.83.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.